Zocor Lawyers No Longer Accepting New Cases

The Zocor lawyers at Saiontz & Kirk, P.A. are no longer reviewing potential lawsuits for individuals who have experienced severe muscle damage or kidney problems that may have been caused by use of the cholesterol drug simvastatin at high doses. This page is maintained for informational purposes only.

ZOCOR MUSCLE PROBLEMS

Zocor (simvastatin) is a synthetic statin developed by Merck that is designed to lower cholesterol. It is one of Merck’s best selling drugs and the second best selling cholesterol drug in the world. Generic Zocor is widely available and the active ingredient, simvastatin, is also contained in the drugs Vytorin and Simcor with other medications.

In rare cases, the Zocor muscle problems may result in a condition known as rhabdomyolysis, which involves deterioration of the muscle tissue that can also damage the kidney as the body tries to filter it out.

Symtoms of rhabdomyolysis from Zocor could include:

  • Muscle Cramps
  • Pain
  • Spasms
  • Stiffness
  • Tenderness

A risk of muscle problems from Zocor and similar drugs, known as statins, has been known for some time. However, it appears that the risk may be substantially increased when Zocor 80 mg doses are taken, and the manufacturer failed to adequately warn about the risk.

In June 2011, the FDA called on U.S. doctors to stop prescribing simvastatin 80mg doses to new patients due to the risk of Zocor side effects at those levels. The FDA indicated that the 80mg Zocor dose has the highest rate of muscle injury of any statin and recommended that it only be used by patients who had already taken 80 mg of simvastatin for at least a year without problems.

ZOCOR CLASS ACTION LAWSUIT LAWYERS

The product liability lawyers at Saiontz & Kirk, P.A. reviewed potential ocor class action lawsuits as well as individual claims for people who have experienced muscle damage from Zocor, simvastatin, Vytorin or Simcor. New cases are no longer being accepted. This page is maintained for informational purposes only.